Market Tracker

12/19 9:05am ET

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

32.85
Data as of Dec 18
 +1.34 / +4.27%
Today’s Change
15.64
Today|||52-Week Range
33.43
+31.43%
Year-to-Date

Today’s Trading

Previous close31.50
Today’s open32.07
Day’s range-- - --
Volume1,341,927
Average volume (3 months)1,189,349
Market cap$3.3B
Dividend yield--
Data as of 12/18/2014

Growth & Valuation

Earnings growth (last year)-15.79%
Earnings growth (this year)-107.58%
Earnings growth (next 5 years)--
Revenue growth (last year)-76.67%
P/E ratioNM
Price/Sales1,870.76
Price/Book16.43

Competitors

 Today’s
change
Today’s
% change
AVNRAvanir Pharmaceutica...+0.07+0.41%
ICPTIntercept Pharmaceut...+9.43+6.70%
NPSPNPS Pharmaceuticals ...+0.51+1.41%
--Cosmo Pharmaceutical...-11.95-6.38%
Data as of 12/18/2014

Financials

Next reporting dateMarch 10, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$1.1M
Annual profit (last year)-$37.9M
Net profit margin-3,314.24%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
CAO
Uli Hacksell
Executive VP, Chief Financial &
Business Officer
Stephen R. Davis
Corporate headquarters
San Diego, California

Forecasts